Page 91 - Technology Platform News Today

WALLDORF - SAP SE today announced that it has extended the contract of Dr. Juergen Mueller, Chief Technology Officer of SAP SE, for another three years until the end of 2027. Mueller joined...

SoFi Technologies, Inc. (NASDAQ:SOFI – Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 209,900,000 shares, a growth of 36.0% from the February 29th total of 154,360,000 shares. Approximately 23.2% of the company’s shares are short sold. […]

SoFi Technologies, Inc. (NASDAQ:SOFI – Get Free Report) was up 1.5% during mid-day trading on Wednesday . The company traded as high as $7.36 and last traded at $7.31. Approximately 10,422,979 shares changed hands during trading, a decline of 82% from the average daily volume of 56,472,578 shares. The stock had previously closed at $7.20. […]

This latest addition introduces a suite of advanced features to fortify SAP environments and address global enterprises evolving security needs.

Shares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) fell 2% on Thursday . The stock traded as low as $21.67 and last traded at $21.74. 19,963 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 791,242 shares. The stock had previously closed at $22.18. Wall Street Analysts […]

Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist...

REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) dropped 2% on Thursday . The stock traded as low as $21.67 and last traded at $21.74. Approximately 19,963 shares traded hands during trading, a decline of 97% from the average daily volume of 791,242 shares. The stock had previously closed at $22.18. Wall Street Analysts Forecast Growth […]

Shares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) fell 2% on Thursday . The stock traded as low as $21.67 and last traded at $21.74. 19,963 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 791,242 shares. The stock had previously closed at $22.18. Wall Street Analysts […]

Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman primate durability data in 2H 2024 Proof of...

Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman...